Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attackYuan Fang, Ying–Hong Shi, Yufu Zhou et al.|Hepatology|2022Cited by 158
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cellsGui‐Qi Zhu, Jia Fan, Zheng Tang et al.|Signal Transduction and Targeted Therapy|2025Cited by 16